I received some interesting comments on last week's posts about the necessity for investment in improving self-care to improve value for the NHS. Most of my posts concerned the implications of some recent work on diabetes and also articles in the Lancet from last Friday on co-morbidities in Scotland.

On 25 April a report was published in Diabetic Medicine, co-authored by York Health Economic forum, Diabetes UK Joseph Rowntree Development Fund and Sanofi Aventis. One aspect of this report were the frightening statistics showing how much more will be spent on diabetes in 2035 if current trends continue. Whilst I never find disease-specific trends over 23 years convincingly accurate – it is a lot.